Voluntis and Sanofi to deliver digital insulin titration solutions

Medical Devices Directory Forums Business Partnering Voluntis and Sanofi to deliver digital insulin titration solutions

This topic contains 0 replies, has 1 voice, and was last updated by Profile photo of Brückenkopf GmbH Brückenkopf GmbH 1 month, 2 weeks ago.

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #4053

    Sanofi and Voluntis announced a non-exclusive agreement to deliver digital insulin titration solutions, featuring a mobile phone application designed to help improve decision-making and self-management of type 2 diabetes for people treated with basal insulin. The application will also enable remote monitoring by health care teams. The agreement reinforces the existing alliance between the two companies, established in 2011, by expanding both its scope and geography.

    The alliance will leverage Sanofi’s expertise in bringing innovative treatments to people living with diabetes and Voluntis’ experience in creating companion software. Sanofi and Voluntis will launch pilot programs using the mobile phone application in North America and several European countries. The application received FDA clearance and the CE mark in 2016.

    Sanofi and Voluntis have worked together over several years to develop innovative digital solutions. Their alliance began in 2011 with the development of Diabeo®, a software medical device that helps people with diabetes in France to manage their basal-bolus treatment.

    Share
Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.

Share